Orrell J M, Neithercut W D, Henderson J, Spooner R J, McGuire G, Frier B M
Department of Pathological Biochemistry and Diabetes, Gartnavel General Hospital, Glasgow, Scotland.
Diabetes Res Clin Pract. 1990 Aug-Sep;10(1):51-7. doi: 10.1016/0168-8227(90)90081-4.
Aspartate aminotransferase, alanine aminotransferase and gamma-glutamyl transferase activities were measured in sera from 411 diabetic outpatients and were raised in 26 (6.4%), 34 (8.3%) and 62 (15.2%) patients, respectively. Serum total bile acid concentrations were raised in 4 patients (1%). Percentage glycated hemoglobin A1, serum fructosamine concentration and plasma glucose concentration were also measured. No relationship between the presence of raised enzyme activity and mature age, short duration of diabetic treatment regimen or glycemic control was found. Twenty-six patients with an alanine aminotransferase activity greater than 60 U/l were reviewed at 23 +/- 6.5 weeks. The activity of this enzyme had fallen to within the reference interval in 15 (58%). In the other 11 patients, its median activity was 75 U/l (range 51-181 U/l). Median gamma-glutamyl transferase activity had risen in these 11 patients from 78 U/l to 93 U/l (P less than 0.01). No statistical differences in treatment regimen or glycemic control were found between these two groups. Raised liver-associated enzyme activity in treated stabilised diabetic outpatients should therefore not be attributed to poor glycemic control or diabetic treatment regimen.
对411名糖尿病门诊患者的血清进行了天冬氨酸转氨酶、丙氨酸转氨酶和γ-谷氨酰转移酶活性检测,结果分别有26例(6.4%)、34例(8.3%)和62例(15.2%)患者上述酶活性升高。4例患者(1%)血清总胆汁酸浓度升高。同时检测了糖化血红蛋白A1百分比、血清果糖胺浓度和血浆葡萄糖浓度。未发现酶活性升高与成年、糖尿病治疗疗程短或血糖控制之间存在关联。对26例丙氨酸转氨酶活性大于60 U/L的患者在23±6.5周时进行了复查。其中15例(58%)该酶活性已降至参考区间内。在另外11例患者中,其酶活性中位数为75 U/L(范围51 - 181 U/L)。这11例患者γ-谷氨酰转移酶活性中位数从78 U/L升至93 U/L(P<0.01)。两组在治疗方案或血糖控制方面未发现统计学差异。因此,在病情稳定的接受治疗的糖尿病门诊患者中,肝脏相关酶活性升高不应归因于血糖控制不佳或糖尿病治疗方案。